Scientists’ Discovery Could Save Thousands of Lives in Emergency
Rooms and on Battlefield The lives of 33,000 people in the
United States alone could be saved each year based on the
collaborative discovery of three scientists from UMD, the
University of Minnesota Medical School—Duluth and the University
of Minnesota Medical School – Minneapolis. Matthew Andrews,
Ph.D., Lester R. Drewes, Ph.D, and Gregory Beilman, M.D. have
designed a low volume resuscitation fluid that may increase the
survival rates of people who die from hemorrhagic shock. The
proprietary product is called Tamiasyn™ which potentially will
allow the human body to endure severe blood loss for an extended
period of time and also inhibit human organ damage during
resuscitation. The University of Minnesota’s Office for
Technology Commercialization in Minneapolis has authorized a
development stage company to hold an exclusive global license to
market the product. VitalMedix™ intends to market Tamiasyn™ in
combination with a hemorrhagic shock trea